BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 31758946)

  • 1. Treatment of oxidative stress-induced pain and inflammation with dexketoprofen trometamol loaded different molecular weight chitosan nanoparticles: Formulation, characterization and anti-inflammatory activity by using in vivo HET-CAM assay.
    Öztürk AA; Kıyan HT
    Microvasc Res; 2020 Mar; 128():103961. PubMed ID: 31758946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diclofenac sodium loaded PLGA nanoparticles for inflammatory diseases with high anti-inflammatory properties at low dose: Formulation, characterization and in vivo HET-CAM analysis.
    Öztürk AA; Namlı İ; Güleç K; Kıyan HT
    Microvasc Res; 2020 Jul; 130():103991. PubMed ID: 32105668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
    Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
    Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
    [No Abstract]   [Full Text] [Related]  

  • 4. Ketorolac Tromethamine Loaded Nano-Spray Dried Nanoparticles: Preparation, Characterization, Cell Viability, COL1A1 Gene Simulation and Determination of Anti-inflammatory Activity by
    Öztürk AA; Çevikelli T; Tilki EK; Güven UM; Kıyan HT
    Curr Drug Deliv; 2023; 20(6):830-840. PubMed ID: 36698231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Orally Applicable, Combinatorial Drug-Loaded Nanoparticles for the Treatment of Fibrosarcoma.
    Demirbolat GM; Altintas L; Yilmaz S; Degim IT
    J Pharm Sci; 2018 May; 107(5):1398-1407. PubMed ID: 29339136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oseltamivir phosphate loaded pegylated-Eudragit nanoparticles for lung cancer therapy: Characterization, prolonged release, cytotoxicity profile, apoptosis pathways and in vivo anti-angiogenic effect by using CAM assay.
    Yurtdaş-Kırımlıoğlu G; Güleç K; Görgülü Ş; Kıyan HT
    Microvasc Res; 2022 Jan; 139():104251. PubMed ID: 34520775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined site-specific release retardant mini-matrix tablets (C-SSRRMT) for extended oral delivery of dexketoprofen trometamol:
    Sweed NM; Basalious EB; Nour SA
    Drug Dev Ind Pharm; 2019 Nov; 45(11):1777-1787. PubMed ID: 31418598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.
    Shinde UA; Joshi PN; Jain DD; Singh K
    Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexketoprofen trometamol: clinical evidence supporting its role as a painkiller.
    Rodríguez MJ; Arbós RM; Amaro SR
    Expert Rev Neurother; 2008 Nov; 8(11):1625-40. PubMed ID: 18986233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Phytotherapy Application: Preparation, Characterization, Antioxidant Activities and Determination of Anti-inflammatory Effects by
    Ismailovi N; Kıyan HT; Öztürk AA
    Curr Drug Deliv; 2024; 21(6):901-916. PubMed ID: 37018530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and corneal permeation of ketorolac tromethamine-loaded chitosan nanoparticles.
    Fathalla ZM; Khaled KA; Hussein AK; Alany RG; Vangala A
    Drug Dev Ind Pharm; 2016; 42(4):514-24. PubMed ID: 26407208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
    Rukmangathen R; Yallamalli IM; Yalavarthi PR
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
    [No Abstract]   [Full Text] [Related]  

  • 13. Preclinical and clinical development of dexketoprofen.
    Mauleón D; Artigas R; García ML; Carganico G
    Drugs; 1996; 52 Suppl 5():24-45; discussion 45-6. PubMed ID: 8922555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular anti-inflammatory activity of prednisolone acetate loaded chitosan-deoxycholate self-assembled nanoparticles.
    Hanafy AF; Abdalla AM; Guda TK; Gabr KE; Royall PG; Alqurshi A
    Int J Nanomedicine; 2019; 14():3679-3689. PubMed ID: 31239660
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
    Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles.
    Baksi R; Singh DP; Borse SP; Rana R; Sharma V; Nivsarkar M
    Biomed Pharmacother; 2018 Oct; 106():1513-1526. PubMed ID: 30119227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of an environmentally friendly octenylsuccinic anhydride modified pH-sensitive chitosan nanoparticle drug delivery system to alleviate inflammation and oxidative stress.
    Yu Z; Ma L; Ye S; Li G; Zhang M
    Carbohydr Polym; 2020 May; 236():115972. PubMed ID: 32172827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
    Bagre AP; Jain K; Jain NK
    Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells.
    Kumar SP; Birundha K; Kaveri K; Devi KT
    Int J Biol Macromol; 2015; 78():87-95. PubMed ID: 25840152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursolic acid-loaded chitosan nanoparticles induce potent anti-angiogenesis in tumor.
    Jin H; Pi J; Yang F; Wu C; Cheng X; Bai H; Huang D; Jiang J; Cai J; Chen ZW
    Appl Microbiol Biotechnol; 2016 Aug; 100(15):6643-6652. PubMed ID: 26883344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.